2022
DOI: 10.1016/j.xkme.2022.100527
|View full text |Cite
|
Sign up to set email alerts
|

Medication Holds in CKD During Acute Volume-Depleting Illnesses: A Randomized Controlled Trial of a “Sick-Day” Protocol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 19 publications
0
10
0
Order By: Relevance
“…Of the 10 included studies, [ 17 – 25 ] eight were original articles [ 17 – 22 , 25 , 26 ], one was a letter to the editor but contained sufficient original data [ 24 ] and one was a systematic review [ 23 ]. Table 2 shows the characteristics of the included studies, while Appendix 3 provides additional study attributes such as major findings and study limitations.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Of the 10 included studies, [ 17 – 25 ] eight were original articles [ 17 – 22 , 25 , 26 ], one was a letter to the editor but contained sufficient original data [ 24 ] and one was a systematic review [ 23 ]. Table 2 shows the characteristics of the included studies, while Appendix 3 provides additional study attributes such as major findings and study limitations.…”
Section: Resultsmentioning
confidence: 99%
“…Five studies (50%) explored the development, usability and/or implementation of sick day interventions and three studies (30%) focused on current practice of providing sick day management advice. A randomised controlled trial, [ 25 ] an observational primary study [ 22 ] and a systematic review [ 23 ] explored outcomes. Studies were carried out in 4 countries.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Fink et al address this issue by assessing the efficacy of a sick day protocol in a randomized control trial that included 315 patients with stage 3-5 CKD treated with medications that could contribute to AKI: RASi, diuretics, non-steroidal antiinflammatory drugs, or metformin. 10 Patients were randomized to usual care or an education program that consisted of two elements: (1) written educational materials that describe and define sick days and instruct patients to stop specific medications for up to 48 hours while sick and (2) an interaction voice response system (IVRS) that calls patient weekly to survey for sick-day events and assess adherence to the protocol. While the J o u r n a l P r e -p r o o f IVRS component does not deliver educational content, it serves as a reminder about the recommended sick day protocol, playing a key role in program sustainability.…”
mentioning
confidence: 99%